Product Description
Procure the laureate Duovir-E Kit (Lamivudine Duovir E Kit Tablet) at the lowest price with swift export options. Astoundingly crafted by Cipla Ltd., this sensational kit features a white Lamivudine/Zidovudine tablet and a yellow Efavirenz capsule-meticulously combined to provide robust oral HIV-1 therapy for adults. WHO prequalified and FDA approved (in some countries), Duovir-E Kit is prescribed as a once-daily regimen to help manage HIV infection. Order today to experience assured quality, 24-month shelf life, and trusted patient care. Consult your physician before use.
Specialized Usage and Features of Duovir-E Kit
Lamivudine Duovir E Kit Tablet is designed for adults undergoing HIV-1 treatment, requiring strict prescription guidance. Its commercial value lies in hospitals and clinics as a reliable fixed-dose antiviral. Noteworthy features include a two-tablet, one-capsule strip tailored for daily oral dosing, color-coded for clarity-white (tablets), yellow (capsule)-and backed by WHO prequalification, ensuring global therapeutic quality. Its comprehensive formulation simplifies complex multi-drug regimens, supporting enhanced patient compliance and clinical outcomes.
Supply Ability, Packaging, and Export Logistics
We ensure consistent supply ability of Lamivudine Duovir E Kit Tablet for exporter, supplier, and trader needs across the global market. Each kit is safely handed over in a boxed pack with strip packaging inside, ideal for bulk dispatch and international shipping. With ready stock at our Indian FOB port, swift international orders are efficiently dispatched to meet export market demands, providing logistical assurance and premium product integrity from origin to delivery.
FAQ's of Lamivudine Duovir E Kit Tablet:
Q: How should Duovir-E Kit be taken for optimal effectiveness?
A: Take Duovir-E Kit orally, as prescribed by your physician, typically once daily at the same time. Do not stop abruptly, and consult your healthcare provider before initiating or making any changes to your regimen.
Q: What makes Duovir-E Kit a preferred choice for HIV treatment?
A: Duovir-E Kit combines Lamivudine, Zidovudine, and Efavirenz in a convenient daily kit, simplifying therapy and ensuring consistent dosing. Its WHO prequalification and select FDA approvals contribute to its acclaim in HIV management.
Q: When should I consult my doctor regarding side effects?
A: Consult your doctor immediately if you experience persistent nausea, dizziness, headache, insomnia, or fatigue. Always read the leaflet and seek medical advice before starting or stopping the medication.
Q: Where is Duovir-E Kit manufactured and who markets it?
A: Duovir-E Kit is manufactured in India and marketed by Cipla Ltd., a renowned pharmaceutical company widely recognized for export quality medicines.
Q: What is the process for ordering Duovir-E Kit internationally?
A: International orders are facilitated through registered exporters and suppliers in India. The product is securely packaged and dispatched from a designated FOB port, maintaining supply chain integrity.
Q: What are the commercial uses and indications for Duovir-E Kit?
A: Duovir-E Kit is used in the clinical management of HIV-1 infection for adults, primarily within hospitals, clinics, and specialized medical institutions.